Diabetic retinopathy has long been treated as a disease of leaky, fragile blood vessels, with anti-VEGF injections as a cornerstone of care. But a growing body of research suggests the story starts earlier — in the retina's neurons and glia — well before the classic vascular signs appear. In this episode, Dr. Saikumar Gandapodi joins us to unpack what it means to view diabetic retinopathy as a neurovascular disease.

We explore the unit that links neurons, glia, and vessels, why anti-VEGF therapy is powerful yet incomplete, and where mechanisms like oxidative stress, chronic inflammation, and neurotrophin decline may fit. Dr. Gandapodi explains how the Netra Restoration Therapy framework approaches the eye as part of a whole metabolic system — always as a complement to, never a replacement for, standard ophthalmic care.

Throughout, we stay honest about the evidence: separating what's established from what's still emerging, distinguishing lab and animal work from human trials, and focusing on what patients living with diabetes can actually take away today.

For decades, keratoconus was described as a purely mechanical, non-inflammatory thinning of the cornea. That story is changing. A growing body of research points to enzymatic activity, oxidative stress, and inflammatory mediators in the tears of people with keratoconus, alongside the mechanical instability that corneal cross-linking is designed to halt.

In this episode, host Maya Rao sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder of Netra Eye Institute, to explore what the evidence actually supports about the biology of keratoconus. They discuss the enduring value of cross-linking, the role of eye rubbing and the ocular surface, and where integrative, adjunct strategies might complement standard care.

Throughout, the conversation stays grounded: established science is separated from emerging hypotheses, no cures are promised, and integrative approaches are framed only as complements to proven ophthalmic treatment.

Normal-tension glaucoma challenges the old idea that glaucoma is simply a disease of high eye pressure. In this episode, Dr. Saikumar Gandapodi joins us to unpack what the evidence actually shows about optic nerve damage occurring at statistically normal intraocular pressures, and why blood flow, vascular regulation, and systemic factors matter so much here.

We explore Flammer syndrome, a described pattern of vascular dysregulation that shows up in some patients with normal-tension glaucoma, and separate what is established from what is still emerging. Dr. Gandapodi explains how conventional pressure-lowering care remains the proven foundation, and where careful, evidence-informed integrative support may complement it.

This is a research-driven conversation for an educated audience curious about the future of eye care. No cures are promised. Instead, we look honestly at the science of neuroprotection, ocular perfusion, and whole-person care around a condition that still keeps clinicians humble.

Glaucoma has long been defined by intraocular pressure — but a growing body of research shows that many patients continue to lose vision even when their pressure is beautifully controlled. Why? In this episode, host Priya Menon sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, practitioner of Ayurvedic Medicine, and Founder and Director of Netra Eye Institute, to explore one of the most compelling frontiers in modern eye care: ocular blood flow and vascular dysregulation.

Together they unpack the science of optic nerve perfusion, endothelial dysfunction, Flammer Syndrome, oxidative stress, mitochondrial fragility, and the neurotrophic decline that leaves retinal ganglion cells vulnerable. Dr. Gandapodi translates concepts from vascular biology, functional medicine, and network pharmacology into an accessible framework — explaining where conventional, pressure-focused management is powerful, where it can fall short, and where adjunct, systems-based strategies may add value.

This is not a conversation about replacing surgery or medication. It is an evidence-informed exploration of the broader biological environment surrounding the optic nerve — from the gut-eye axis to Ginkgo biloba trials — and how Netra Restoration Therapy approaches glaucoma as a multifactorial, whole-person condition. Balanced, rigorous, and forward-looking, this episode is essential listening for patients and clinicians alike.

For decades, glaucoma has been defined and treated almost entirely through the lens of intraocular pressure. But a growing body of peer-reviewed research reveals a far more complex picture: glaucoma is increasingly understood as a multifactorial neurodegenerative disease of the retinal ganglion cells, sharing mechanistic overlap with conditions like Alzheimer's and Parkinson's. In this episode, host Maya Chandra sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, practitioner of Ayurvedic Medicine, and Founder and Director of Netra Eye Institute.

Together they explore the mechanisms conventional care often underemphasizes — reduced ocular blood flow and Flammer Syndrome, mitochondrial dysfunction, oxidative stress, neurotrophin deprivation including BDNF, excitotoxicity, neuroinflammation, and even ferroptosis. Dr. Gandapodi explains how integrative ophthalmology and Netra Restoration Therapy approach the optic nerve as living neural tissue embedded in a whole-body biological environment, including the emerging gut-eye axis.

Grounded in landmark studies and honest about the quality of evidence, this conversation reframes traditional herbal medicine through modern network pharmacology while making clear that these approaches are adjunctive and complementary — never a replacement for proven pressure-lowering therapy. The goal is not to abandon what works, but to ask what more we can do to protect vision over a lifetime.

For decades, textbooks defined keratoconus as a 'non-inflammatory' degenerative thinning of the cornea. But a growing body of peer-reviewed research is challenging that assumption, revealing elevated inflammatory cytokines, oxidative stress, mitochondrial dysfunction, and altered protease activity in the tears and corneal tissue of affected patients. In this episode, host Maya Iyer sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder and Director of Netra Eye Institute, to explore why keratoconus may be far more of an inflammatory and systemic disease than its classic definition suggests.

Together they trace the mechanistic story — from matrix metalloproteinases and IL-6 and TNF-alpha in tear film, to reactive oxygen species, glutathione depletion, and the biomechanical collapse of collagen crosslinks. Dr. Gandapodi explains where conventional pillars like corneal crosslinking, rigid contact lenses, and transplantation excel, and where adjunct opportunities may exist to address the underlying biological terrain, including the gut-eye axis, eye rubbing, atopy, and oxidative burden.

The conversation introduces Netra Restoration Therapy (NRT) as an integrative, complementary framework — never a replacement for standard care — and interprets traditional herbal medicine through the modern lenses of network pharmacology and systems biology. Balanced, evidence-aware, and intellectually honest, this episode is for clinicians, patients, and curious minds who want to understand keratoconus not as an isolated corneal shape problem, but as a whole-person biological process.